Minocycline restores striatal tyrosine hydroxylase in GDNF heterozygous mice but not in methamphetamine-treated mice

17Citations
Citations of this article
14Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Inflammation, phospho-p38 MAPK activation, and a reduction in glial cell line-derived neurotrophic factor (GDNF) occur in Parkinson's disease. Microglial activation in the substantia nigra and a tyrosine hydroxylase deficit in the striatum of 3-month-old GDNF heterozygous (GDNF+/-) mice were previously reported and both were exacerbated by a toxic methamphetamine binge. The current study assessed the effects of minocycline on these methamphetamine-induced effects. Minocycline (45 mg/kg, i.p. × 14 days post-methamphetamine or saline injections) reduced microglial activation and phospho-p38 MAPK in the substantia nigra of saline-treated GDNF+/- mice and in methamphetamine-treated wildtype and GDNF+/- mice. Although minocycline increased tyrosine hydroxylase-immunoreactivity in GDNF+/- mice, it did not attenuate the methamphetamine-induced reduction of tyrosine hydroxylase. The results suggest that neuroinflammation is deleterious to the dopamine system of GDNF+/- mice but is not the primary cause of methamphetamine-induced damage to the dopamine system in either GDNF+/- or wildtype mice. © 2008 Elsevier Inc. All rights reserved.

Cite

CITATION STYLE

APA

Boger, H. A., Middaugh, L. D., Granholm, A. C., & McGinty, J. F. (2009). Minocycline restores striatal tyrosine hydroxylase in GDNF heterozygous mice but not in methamphetamine-treated mice. Neurobiology of Disease, 33(3), 459–466. https://doi.org/10.1016/j.nbd.2008.11.013

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free